Condition: Gastritis · Sponsor: Daewoong Pharmaceutical Co. LTD.
This study aims to evaluate the efficacy of Fexuclue tablets in improving gastrointestinal symptoms based on patient-reported outcomes (PROs), by comparing assessments before and after treatment.
This description comes directly from the study's public registry record.
So Heui Kim · 82-10-2994-5887 · 2210325@daewoong.co.kr
Always discuss trial participation with your own doctor first.
| Masong Kim Internal Medicine Clinic | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06948487